Trial intelligence / Profile preview

S-1 and Bevacizumab in Elderly Patients With Colorectal Cancer

NCT00569699Phase 2Completed

Sponsor
Taiho Pharmaceutical Co., Ltd.
Start
Oct 2007
Primary completion
Mar 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of tegafur in colorectal cancer (CRC), sponsored by Taiho Pharmaceutical Co., Ltd.. Started Oct 2007; status: completed.

02

Drugs

tegafur
03

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on NCT00569699.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00569699.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call